share_log

仟源医药(300254.SZ):仟源海力生通过高新技术企业重新认定

Shanxi C&Y Pharmaceutical Group (300254.SZ): Shanxi C&Y Pharmaceutical Group has been recertified as a high-tech enterprise.

Gelonghui Finance ·  Dec 31, 2024 16:51

On December 31, Gelonghui reported that Shanxi C&Y Pharmaceutical Group (300254.SZ) announced that its subsidiary, Zhejiang Shanxi C&Y Lisheng Pharmaceutical Co., Ltd. (referred to as "Shanxi C&Y Lisheng"), has learned from the recent announcement by the Office of the Leading Group for the Management of National High-tech Enterprise Recognition regarding the record-keeping of high-tech enterprises recognized by institutions in Zhejiang Province for 2024 that Shanxi C&Y Lisheng has passed the re-recognition as a high-tech enterprise. The certificate number is: GR202433009288, the issuance date is December 6, 2024, and the validity period is three years.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment